(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 496.14 | 494.67 | 0.30 | 1129.82 | 1092.99 | 3.37 | 1129.82 | 1092.99 | 3.37 |
| Other Income | 1.73 | 0.49 | 253.06 | 2.86 | 13.09 | -78.15 | 2.86 | 13.09 | -78.15 |
| PBIDT | 2.87 | -19.05 | -115.07 | -150.80 | -87.76 | 71.83 | -150.80 | -87.76 | 71.83 |
| Interest | 18.08 | 21.28 | -15.04 | 47.77 | 19.61 | 143.60 | 47.77 | 19.61 | 143.60 |
| PBDT | -15.21 | -40.33 | -62.29 | -198.57 | -107.37 | 84.94 | -198.57 | -107.37 | 84.94 |
| Depreciation | -2.41 | -2.34 | 2.99 | 23.23 | 36.14 | -35.72 | 23.23 | 36.14 | -35.72 |
| PBT | -12.80 | -37.99 | -66.31 | -221.80 | -143.51 | 54.55 | -221.80 | -143.51 | 54.55 |
| TAX | 4.24 | -16.48 | -125.73 | -46.09 | -40.53 | 13.72 | -46.09 | -40.53 | 13.72 |
| Deferred Tax | 4.24 | -18.08 | -123.45 | -46.09 | -42.13 | 9.40 | -46.09 | -42.13 | 9.40 |
| PAT | -17.04 | -21.51 | -20.78 | -175.71 | -102.98 | 70.63 | -175.71 | -102.98 | 70.63 |
| Equity | 369.84 | 369.84 | 0.00 | 369.84 | 369.84 | 0.00 | 369.84 | 369.84 | 0.00 |
| PBIDTM(%) | 0.58 | -3.85 | -115.02 | -13.35 | -8.03 | 66.23 | -13.35 | -8.03 | 66.23 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1935.25 |
| Dr. Reddys Labs. | 1245.50 |
| Cipla | 1438.75 |
| Zydus Lifesciences | 1150.50 |
| Lupin | 2496.05 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: